1. Home
  2. KELYB vs ACRS Comparison

KELYB vs ACRS Comparison

Compare KELYB & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

N/A

Current Price

$8.86

Market Cap

321.6M

ML Signal

N/A

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$2.67

Market Cap

314.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
ACRS
Founded
1946
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
321.6M
314.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
KELYB
ACRS
Price
$8.86
$2.67
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.75
AVG Volume (30 Days)
704.0
1.2M
Earning Date
02-12-2026
11-06-2025
Dividend Yield
3.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,392,800,000.00
$15,742,000.00
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.46
N/A
52 Week Low
$8.38
$1.05
52 Week High
$15.15
$3.48

Technical Indicators

Market Signals
Indicator
KELYB
ACRS
Relative Strength Index (RSI) 35.78 41.24
Support Level $8.71 $2.88
Resistance Level $8.95 $3.04
Average True Range (ATR) 0.18 0.18
MACD 0.04 -0.07
Stochastic Oscillator 41.74 20.12

Price Performance

Historical Comparison
KELYB
ACRS

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: